Histamindihydrochlorid-Kontrollösung Bencard Allergie

Histamindihydrochlorid-Kontrollösung Bencard Allergie is a diagnostic solution containing the active ingredient histamine dihydrochloride in an unspecified strength. It is supplied as a sterile aqueous solution intended for cutaneous application during allergy testing procedures in the European market.

Histamindihydrochlorid-Kontrollösung Bencard Allergie is employed as a control agent in skin allergy testing to assess immediate‑type hypersensitivity reactions. It helps clinicians verify test reliability and compare patient responses.

- Positive control for prick and scratch tests - Evaluation of histamine skin reactivity - Standardization of allergen test results - Assessment of patient’s cutaneous vascular response - Used in research settings to study wheal‑and‑flare mechanisms

Adverse reactions to histamine dihydrochloride solution are generally limited to the application site, but systemic effects can occur in rare cases.

Common: - Localized erythema at the test site - Transient wheal formation lasting 15–30 minutes - Mild itching or burning sensation - Small amount of edema around the injection area

Serious: - Generalized urticaria - Anaphylactic reaction (rare) - Severe hypotension - Bronchospasm - Cardiovascular instability

When using Histamindihydrochlorid-Kontrollösung Bencard Allergie, clinicians should consider patient safety and test accuracy.

- Verify patient’s history of severe allergic reactions before testing - Avoid use on compromised or infected skin - Ensure appropriate concentration to prevent exaggerated responses - Monitor patients for systemic reactions during and after application - Have emergency equipment and medications readily available - Document any unexpected reactions for future reference

Histamine dihydrochloride solution may interact with medications that influence histamine pathways or vascular tone.

Avoid: - Antihistamines (e.g., cetirizine, diphenhydramine) taken within 24 hours, which can suppress the wheal‑and‑flare response - Systemic mast cell stabilizers that may diminish skin reactivity

Use with caution: - Beta‑blockers, which can exacerbate anaphylactic reactions - ACE inhibitors, potentially enhancing vascular permeability - Vasodilators that may augment local skin response - Sedatives that could mask early signs of systemic reactions